Flx Bio, Inc. announced it raised $29.9 Million in an initial filing from an offering of $59.9 Million

Jan 04, 2018•almost 8 years ago

Amount Raised

$29.9 Million

San FranciscoBiotechnology

Company Information

Company

FLX Bio, Inc.

Location

561 ECCLES AVENUE

San Francisco, California, United States

About

FLX Bio (“FLX”) is a biotechnology company focused on the discovery, development, and commercialization of immunotherapies.

6 contacts

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech